British company RTS Life Science, supplier of automated sample management and pharmaceutical testing systems, has announced a new US headquarters.
British company RTS Life Science, supplier of automated sample management and pharmaceutical testing systems, has announced a new US headquarters and the formation of ‘RTS Life Science LLC’. Following the acquisition earlier this year of Hatch Science, a Massachusetts based life science company, both products and services have now been successfully integrated into the Group.
With a US team of approximately 20 mechanical, electrical, software, sales and support staff and a design engineering and manufacturing facility, RTS is reported to now be able to provide sales, engineering and support services to its US client base of sample management, biobanking and pharmaceutical testing customers.
Gary Walsh, CEO of RTS commented. “Our strategy is to strengthen our capabilities in the US which has always represented a substantial part of our business. We now have an extended localized team and have fully integrated our US operations into the business.”
For further information regarding RTS Life Science or automation solutions for sample management, biobanking or pharmaceutical testing applications visit www.rts-group.com
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.